In the News

Finding a possible early treatment for COVID-19 in a 40-year-old antidepressant

View Content

Sharyn Alfonsi reports on the unusual path fluvoxamine, a drug commonly used to treat obsessive-compulsive disorder, has had to becoming an early treatment candidate for COVID-19

Leave a Reply

Your email address will not be published. Required fields are marked *